Literature DB >> 10655320

Decreased sperm function of patients with myotonic muscular dystrophy.

M L Hortas1, J A Castilla, M T Gil, J Molina, M L Garrido, M Morell, M Redondo.   

Abstract

Myotonic muscular dystrophy (MMD) is a genetic disease caused by a defective enzyme, myotoninkinase. Male patients with MMD are reported to have reduced fertility. The purpose of this work was to study sperm capacitation and acrosome reaction in the ejaculates of sterile males with MMD and of healthy males (control group). The expression of the specific D-mannose receptors was explored by microscopic examination and by flow cytometry analysis. In addition, the binding patterns of Pisum sativum (PSA) lectin to acrosome content and outer acrosomal membrane in the spermatozoa of each group were analysed. Both the capacitation and the acrosome reaction in the spermatozoa of the MMD group were deficient and these findings strongly suggest that these anomalies may account for the sterility of these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655320     DOI: 10.1093/humrep/15.2.445

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Infertile Males with Muscle Weakness: Keep Your Eyes Open for Myotonic Dystrophy.

Authors:  Partha P Chakraborty; Sugata N Biswas; Shinjan Patra; Gouranga Santra
Journal:  J Obstet Gynaecol India       Date:  2016-05-03

2.  Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I.

Authors:  Banchhita Sahu; Ozkan Ozturk; Nandita Deo; Karen Fordham; Massimo Ranierri; Paul Serhal
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

3.  Preimplantation Genetic Diagnosis for Myotonic Dystrophy Type 1 and Analysis of the Effect of the Disease on the Reproductive Outcome of the Affected Female Patients.

Authors:  Raquel María Fernández; María Dolores Lozano-Arana; Beatriz Sánchez; Ana Peciña; Juan Carlos García-Lozano; Salud Borrego; Guillermo Antiñolo
Journal:  Biomed Res Int       Date:  2017-11-14       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.